Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Granuloma, Plasma Cell × ceritinib × Thoracic × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 3 Lymphoid 3 CNS 2 Thoracic 1 Sarcoma 1 Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 7 Adenocarcinoma of Lung 4 Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Brain Neoplasms 1 ALK-positive Non-small Cell Lung Cancer 1 ALK-positive NSCLC 1

Interventions

ceritinib 1 Crizotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05100134 2025-12-09

Managed Access Programs for LDK378, Ceritinib

Novartis

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡